Cohen, Hillel P. http://orcid.org/0000-0002-8758-0890
Turner, Matthew http://orcid.org/0009-0001-3351-4150
McCabe, Dorothy http://orcid.org/0009-0007-9583-4671
Woollett, Gillian R. http://orcid.org/0000-0002-9336-2769
Article History
Accepted: 24 July 2023
First Online: 5 August 2023
Declarations
:
: The Biosimilars Forum paid for medical writing support and the Open Access charges.
: HPC is an employee of Sandoz Inc. MT is an employee of Fresenius Kabi. DM is an employee of Boehringer Ingelheim. GRW is an employee of Samsung Bioepis. The authors are all members of the Science and Education Committee of the Biosimilars Forum. HPC and DM are co-chairs of this committee. The Biosimilars Forum is a nonprofit biosimilars trade association whose mission is to promote education and policy advancement on biosimilars in the USA, with the intent of expanding access and availability of biological medicines and improving healthcare. The views expressed here are those of the authors in their roles with the Biosimilars Forum and not of their respective companies. Furthermore, the contents may not reflect the positions of all member companies of the Biosimilars Forum.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: All authors contributed to the drafting and review of the manuscript. The final manuscript was approved by all authors who take responsibility for the content.